Bluebook
Diagnostics and Tools May 2023
2023 - May: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Oncimmune Ltd was acquired by Freenome, Inc.
- Gyrus Capital S.A. announced its acquisition of LRE Medical GmbH
- Viva Biotech (Shanghai) Ltd. closed a $14.5MM Series A Financing, led by Jiangsu Shengze Investment Co.,Ltd., VVB Fund, Shenzhen Zhongjince Investment Co., Ltd., VVB Fund